VSEE HEALTH, INC. Files 8-K on Shareholder Nominations
Ticker: VSEEW · Form: 8-K · Filed: Oct 28, 2025 · CIK: 1864531
| Field | Detail |
|---|---|
| Company | Vsee Health, Inc. (VSEEW) |
| Form Type | 8-K |
| Filed Date | Oct 28, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, shareholder-nomination, corporate-action
Related Tickers: VSEE
TL;DR
VSEE HEALTH filed an 8-K for shareholder nominations - board shakeup incoming?
AI Summary
VSEE HEALTH, INC. filed an 8-K on October 28, 2025, reporting events as of October 22, 2025. The filing primarily concerns shareholder nominations under Exchange Act Rule 14a-11 and other events. VSEE HEALTH, INC. was formerly known as DIGITAL HEALTH ACQUISITION CORP. and changed its name on May 26, 2021.
Why It Matters
This filing indicates potential changes in the company's board composition or governance structure, which could impact strategic direction and shareholder value.
Risk Assessment
Risk Level: medium — Filings related to shareholder nominations and potential governance changes can introduce uncertainty and volatility.
Key Players & Entities
- VSEE HEALTH, INC. (company) — Registrant
- DIGITAL HEALTH ACQUISITION CORP. (company) — Former company name
- October 22, 2025 (date) — Earliest event reported date
- October 28, 2025 (date) — Report date
- Exchange Act Rule 14a-11 (regulation) — Subject of filing
FAQ
What specific shareholder nominations were made by VSEE HEALTH, INC.?
The filing indicates that shareholder nominations were made under Exchange Act Rule 14a-11, but the specific details of these nominations are not provided in the provided text.
What are the 'Other Events' mentioned in the filing?
The provided text lists 'Other Events' as an item information, but does not specify what these events entail.
When did VSEE HEALTH, INC. change its name from DIGITAL HEALTH ACQUISITION CORP.?
VSEE HEALTH, INC. changed its name from DIGITAL HEALTH ACQUISITION CORP. on May 26, 2021.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is October 22, 2025.
What is the primary purpose of this Form 8-K filing for VSEE HEALTH, INC.?
The primary purpose of this Form 8-K filing is to report shareholder nominations pursuant to Exchange Act Rule 14a-11 and to disclose other events.
Filing Stats: 802 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2025-10-28 16:16:16
Key Financial Figures
- $0.0001 — e on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq
- $11.50 — (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq St
Filing Documents
- vsee8k102825.htm (8-K) — 29KB
- 0001185185-25-001551.txt ( ) — 236KB
- vsee-20251022.xsd (EX-101.SCH) — 4KB
- vsee-20251022_def.xml (EX-101.DEF) — 26KB
- vsee-20251022_lab.xml (EX-101.LAB) — 36KB
- vsee-20251022_pre.xml (EX-101.PRE) — 25KB
- vsee8k102825_htm.xml (XML) — 6KB
08 Shareholder Director Nominations
Item 5.08 Shareholder Director Nominations. To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.
01 Other Events
Item 8.01 Other Events. On October 22, 2025, the board of directors (the "Board") of VSee Health, Inc. (the "Company") established December 15, 2025 as the date of the Company's 2025 annual meeting of stockholders (the "2025 Annual Meeting") and set November 20, 2025 as the record date for determining stockholders who are eligible to receive notice of and vote at the 2025 Annual Meeting. The Company will publish additional details regarding the exact time, location and matters to be voted on at the 2025 Annual Meeting in the Company's proxy statement for the 2025 Annual Meeting. In order for stockholder proposals to be presented at the 2025 Annual Meeting, including by means of inclusion of a stockholder proposal in the Company's proxy materials under Rule 14a-8 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Company must receive proper notice at the Company's principal executive offices not later than the close of business on November 7, 2025, which the Company has determined to be a reasonable time before it expects to begin to print and distribute its proxy materials prior to the 2025 Annual Meeting. Any such proposal must also meet the requirements set forth in the rules and regulations of the Securities and Exchange Commission in order to be eligible for inclusion in the proxy materials for the 2025 Annual Meeting. The November 7, 2025 deadline will also apply in determining whether notice of a stockholder proposal is timely for purposes of exercising discretionary voting authority with respect to proxies under Rule 14a-4(c) of the Exchange Act. In addition, pursuant to the Company's amended and restated by-laws, for business to be properly brought before the 2025 Annual Meeting by a stockholder, the Company must receive proper notice at the Company's principal executive offices not later than the close of business on November 7, 2025. In addition to satisfying the foregoing requirements, to comply with the universal proxy rules,